SUBSCRIPTION AGREEMENTTrxade Group • January 22nd, 2019 • Trxade Group, Inc. • Wholesale-drugs, proprietaries & druggists' sundries
The securities offered hereby are speculative and involve a high degree of risk, and should not be purchased by anyone who cannot afford the loss of the entire amount of his or her investment. See “RISK FACTORS,” from our Form 10, as amended (the “Form 10”), first filed with the Securities and Exchange Commission (the “SEC”) on June 11, 2014, our Annual Report on Form 10-K for the period ended December 31, 2017 (the “Form 10-K”) and all subsequent Quarterly Reports on Form 10-Q (collectively, the Form 10 and the Form 10-K, Form 10-Q, and all other public filings with the SEC are referred to hereinafter as the “Public Filings”). The RISK FACTORS from our Public Filings and other information therein are incorporated herein by reference. This offering is not complete without reviewing the information presented in these documents. You can review these documents free of charge at the SEC website, www.SEC.gov.
CONTRIBUTION AGREEMENTContribution Agreement • January 22nd, 2019 • Trxade Group, Inc. • Wholesale-drugs, proprietaries & druggists' sundries • Florida
This Contribution Agreement (the “Agreement”) is made and entered into effective as of 1 January 2019, by and between Alliance Pharma Solutions, LLC, a Delaware limited liability company (“Alliance”), and PanOptic Health, LLC, a Delaware limited liability company (“PanOptic”).
TRXADE GROUP, INC. STOCKHOLDER AGREEMENT January 1, 2018 TRXADE GROUP, INC. STOCKHOLDER AGREEMENTStockholder Agreement • January 22nd, 2019 • Trxade Group, Inc. • Wholesale-drugs, proprietaries & druggists' sundries • Delaware
This Stockholder Agreement (this “Agreement”) is made as of January 1, 2019 by and among Trxade Group, Inc., a Delaware corporation (the “Company”), the persons and entities listed on Exhibit A (each an “Investor,” and collectively, the “Investors”) and the persons and entities listed on Exhibit B (each an “Existing Stockholder,” and collectively, the “Existing Stockholders”). The Existing Stockholders and the Investors are referred to herein collectively as the “Voting Parties.”
LIMITED LIABILITY COMPANY AGREEMENT OF SYNCHEALTH MSO, LLC A DELAWARE LIMITED LIABILITY COMPANYLimited Liability Company Agreement • January 22nd, 2019 • Trxade Group, Inc. • Wholesale-drugs, proprietaries & druggists' sundries • Delaware
This Limited Liability Company Agreement of SyncHealth MSO, LLC (the “Company”) is made and entered into effective as of 1 January 2019 (the “Effective Date”), by and among the Members and the Company.
TECHNOLOGY INTEGRATION AGREEMENTTechnology Integration Agreement • January 22nd, 2019 • Trxade Group, Inc. • Wholesale-drugs, proprietaries & druggists' sundries • Florida
This Technology Integration Agreement (this “Agreement”) is made effective as of 1 January 2019 (the “Effective Date”) by and between Alliance Pharma Solutions, a Delaware limited liability company, having an office at 3840 Land O’ Lakes Blvd., Land O’ Lakes, FL 34639, or its nominee, (“Alliance”), and SyncHealth MSO, LLC, a Delaware limited liability company, having an office at 2107 Gunn Hwy, Odessa, FL 33556 (“SyncHealth”). SyncHealth and Alliance are each referred to herein as a “Party” or collectively as the “Parties.”
